145
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Soy (Glycine max)-Derived Phospholipids Exhibit Potent Anti-Apoptotic Activity

, , , , , & show all
Pages 111-123 | Received 20 May 2004, Accepted 20 May 2004, Published online: 20 May 2004
 

Abstract

We have isolated and identified a soybean phospholipid mixture from unroasted soy (Glycine max) flour that is a potent inhibitor of apoptotic cell death. This phospholipid mixture has been purified from several soy derived materials including soy flour, soy molasses, and crude commercial soy lecithin. Analysis of this bioactive lipid mixture has identified the two major constituents as phosphatidic acid and phosphatidylinositol. This lipid mixture also contains lesser amounts of lysophosphatidic acid, lysophosphatidylinositol, and lysophosphatidylcholine. These phospholipids contain the typical distribution of fatty acids found in soy, predominantly C16:0 and C18:2 (hexadecanoic and 9,12–octadecadienoic) in a 60:40 to 50:50 ratio. Less than 10% of other varieties of fatty acids were identified; the most common other fatty acids found were C18:0, C18:1 and C18:3. Apoptosis inhibition was assessed following serum deprivation of a mouse embryonic stem cell line (C3H–10T1/2). This anti-apoptotic bioassay was used to monitor the purification of the bioactive phospholipid mixture. Of the phospholipids contained in the mixture, lysophosphatidic acid was found to be the most potent inhibitor of apoptotic cell death. The anti-apoptotic factor described here is distinct from the bioactive, well characterized estrogen-like, anti-cancer factor and the Bowman–Birk protease inhibitor, neither of which possess anti-apoptotic activity in this assay.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.